|
US4327725A
(en)
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
|
US4624848A
(en)
|
1984-05-10 |
1986-11-25 |
Ciba-Geigy Corporation |
Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
|
|
US4739044A
(en)
|
1985-06-13 |
1988-04-19 |
Amgen |
Method for derivitization of polynucleotides
|
|
US4757141A
(en)
|
1985-08-26 |
1988-07-12 |
Applied Biosystems, Incorporated |
Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
|
|
US4968509A
(en)
|
1987-07-27 |
1990-11-06 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
|
IT1222414B
(it)
|
1987-07-31 |
1990-09-05 |
Chiesi Farma Spa |
Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
|
|
US4843155A
(en)
|
1987-11-19 |
1989-06-27 |
Piotr Chomczynski |
Product and process for isolating RNA
|
|
IL92966A
(en)
|
1989-01-12 |
1995-07-31 |
Pfizer |
Dispensing devices powered by hydrogel
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
US6040138A
(en)
|
1995-09-15 |
2000-03-21 |
Affymetrix, Inc. |
Expression monitoring by hybridization to high density oligonucleotide arrays
|
|
US5800992A
(en)
|
1989-06-07 |
1998-09-01 |
Fodor; Stephen P.A. |
Method of detecting nucleic acids
|
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
|
ES2111065T5
(es)
|
1991-04-16 |
2005-06-16 |
Nippon Shinyaku Company, Limited |
Procedimiento para producir una dispersion solida.
|
|
US5994056A
(en)
|
1991-05-02 |
1999-11-30 |
Roche Molecular Systems, Inc. |
Homogeneous methods for nucleic acid amplification and detection
|
|
EP0604552B1
(en)
|
1991-09-18 |
1997-02-12 |
Affymax Technologies N.V. |
Method of synthesizing diverse collections of oligomers
|
|
JP3195391B2
(ja)
|
1991-11-14 |
2001-08-06 |
エスエス製薬株式会社 |
徐放性トラピジル錠
|
|
DE69233087T2
(de)
|
1991-11-22 |
2003-12-24 |
Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) |
Verfahren zur Herstellung von Polymerarrays
|
|
US5384261A
(en)
|
1991-11-22 |
1995-01-24 |
Affymax Technologies N.V. |
Very large scale immobilized polymer synthesis using mechanically directed flow paths
|
|
CZ282760B6
(cs)
|
1991-11-22 |
1997-09-17 |
Procter And Gamble Pharmaceuticals, Inc. |
Risedronátové prostředky se zpožděným uvolňováním
|
|
US5348853A
(en)
|
1991-12-16 |
1994-09-20 |
Biotronics Corporation |
Method for reducing non-specific priming in DNA amplification
|
|
US5567583A
(en)
|
1991-12-16 |
1996-10-22 |
Biotronics Corporation |
Methods for reducing non-specific priming in DNA detection
|
|
US6033854A
(en)
|
1991-12-16 |
2000-03-07 |
Biotronics Corporation |
Quantitative PCR using blocking oligonucleotides
|
|
US5461140A
(en)
|
1992-04-30 |
1995-10-24 |
Pharmaceutical Delivery Systems |
Bioerodible polymers for solid controlled release pharmaceutical compositions
|
|
IT1255522B
(it)
|
1992-09-24 |
1995-11-09 |
Ubaldo Conte |
Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
|
|
WO1994008568A1
(fr)
|
1992-10-16 |
1994-04-28 |
Nippon Shinyaku Co., Ltd. |
Procede pour fabriquer des matrices de cire
|
|
US5686105A
(en)
|
1993-10-19 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
KR100477070B1
(ko)
*
|
1994-03-25 |
2006-04-21 |
이소테크니카 인코포레이티드 |
중수소화작용에의한의약품의효능강화법
|
|
US5556752A
(en)
|
1994-10-24 |
1996-09-17 |
Affymetrix, Inc. |
Surface-bound, unimolecular, double-stranded DNA
|
|
DE19514048A1
(de)
|
1995-04-13 |
1996-10-17 |
Rentschler Arzneimittel |
Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern
|
|
KR19990014865A
(ko)
|
1995-05-17 |
1999-02-25 |
피터 이. 브래이브맨 |
소장에서의 소화 및 흡수를 증진시키기 위한, 지방산을 함유한조성물들
|
|
US5545531A
(en)
|
1995-06-07 |
1996-08-13 |
Affymax Technologies N.V. |
Methods for making a device for concurrently processing multiple biological chip assays
|
|
US5854033A
(en)
|
1995-11-21 |
1998-12-29 |
Yale University |
Rolling circle replication reporter systems
|
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
|
EP0880598A4
(en)
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US5869717A
(en)
|
1997-09-17 |
1999-02-09 |
Uop Llc |
Process for inhibiting the polymerization of vinyl aromatics
|
|
JP2001521753A
(ja)
|
1997-10-31 |
2001-11-13 |
アフィメトリックス インコーポレイテッド |
成人臓器及び胎児臓器中の発現プロフィール
|
|
US6020135A
(en)
|
1998-03-27 |
2000-02-01 |
Affymetrix, Inc. |
P53-regulated genes
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
JP2001322933A
(ja)
|
2000-05-15 |
2001-11-20 |
Ucb Sa |
Ｃｄ４０シグナル遮断剤
|
|
US6465014B1
(en)
|
2001-03-21 |
2002-10-15 |
Isp Investments Inc. |
pH-dependent sustained release, drug-delivery composition
|
|
US6960563B2
(en)
|
2001-08-31 |
2005-11-01 |
Morton Grove Pharmaceuticals, Inc. |
Spontaneous emulsions containing cyclosporine
|
|
US20060166972A1
(en)
|
2003-07-11 |
2006-07-27 |
Conn P J |
Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator
|
|
US20080242657A1
(en)
|
2004-03-26 |
2008-10-02 |
Marino Michael J |
Treatment of Tremor with Histamine H3 Inverse Agonists or Hist Amine H3 Antagonists
|
|
WO2007061798A2
(en)
|
2005-11-18 |
2007-05-31 |
Cornell Research Foundation, Inc. |
Nicotinoyl riboside compositions and methods of use
|
|
NZ580662A
(en)
*
|
2007-04-30 |
2012-01-12 |
Abbott Lab |
Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme used in manufacture of medicament for treatment of diabetes or lipid associated disorders
|
|
WO2009070805A2
(en)
|
2007-12-01 |
2009-06-04 |
Asuragen, Inc. |
Mir-124 regulated genes and pathways as targets for therapeutic intervention
|
|
CA2721797C
(en)
|
2008-04-18 |
2018-02-27 |
Gary Zabow |
Magnetic microstructures for magnetic resonance imaging
|
|
EP3225697A3
(en)
|
2010-12-30 |
2017-11-22 |
Foundation Medicine, Inc. |
Optimization of multigene analysis of tumor samples
|
|
US20140045856A1
(en)
|
2012-07-31 |
2014-02-13 |
Boehringer Ingelheim International Gmbh |
4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
|
|
KR101534395B1
(ko)
|
2013-08-01 |
2015-07-09 |
서울대학교산학협력단 |
트라피딜을 유효성분으로 포함하는 골 관련 질환의 예방 또는 치료용 조성물
|
|
WO2017059118A1
(en)
|
2015-09-29 |
2017-04-06 |
Duke University |
Compositions and methods for identifying and treating dystonia disorders
|
|
WO2017117240A1
(en)
|
2015-12-29 |
2017-07-06 |
JONES AND MALTERER TECHNOLOGY INNOVATIONS INCORPORATED, d/b/a JAMTek |
Multi-point synchronizable and scalable lighting control systems
|
|
CA3054674A1
(en)
*
|
2016-04-04 |
2017-12-10 |
Sinopia Biosciences, Inc. |
Treating extrapyramidal syndrome using trapidil
|
|
CA3087925A1
(en)
*
|
2018-02-02 |
2019-08-08 |
Boehringer Ingelheim International Gmbh |
Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors
|
|
EP4069239A4
(en)
|
2019-12-02 |
2023-11-29 |
Sinopia Biosciences, Inc. |
Treating cognitive disorders using trapidil
|
|
IL296788A
(en)
|
2020-03-26 |
2022-11-01 |
Sinopia Biosciences Inc |
Isotopically labeled trepidil histories
|
|
WO2021262786A1
(en)
|
2020-06-24 |
2021-12-30 |
Yale University |
Pank modulators and methods using same
|